Development of HSP90 beta-selective inhibitors as safer anti-cancer agents
Ended Project Grant Awarded Last action
- Award ID
- R41CA247058
- Recipient
-
Grannus Therapeutics, Inc. UEI CKYDPT5R18Z8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $233,195
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Mishawaka, IN 46545, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $233,195 |
Quick answers
Who received award R41CA247058?
R41CA247058 was awarded to Grannus Therapeutics, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2020.
How much is award R41CA247058 worth?
$233,195 has been obligated on R41CA247058.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award